Here is some other vaccine news of note for the week:
> Pfizer's vaccine sales in the third quarter grew 12% to $1.85 billion. Prevnar 13 sales in the U.S. were up 12% due to the timing of government purchases. Release (PDF)
> Pharmacists in Canada are reporting a shortage of GlaxoSmithKline's hep A and B vaccine for travelers Twinrix. CBC article
> A subsidiary of South Korea's GC Pharma received approval to start phase 1 testing of a shingles vaccine. Release
> Enesi Pharma entered an R&D deal to work on vaccines against Chikungunya, Zika and peanut allergy. Release